Insulin Glargine 100IU/ml Injection
Reviewed educational reference: what Insulin Glargine is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Insulin Glargine
- Strength
- 100IU/ml
- Dosage form
- Injection
- Drug class
- Long acting insulin analogue
Related products
No reviewed products are currently published for this generic.
Insulin Glargine 100IU/ml Injection is a long acting analogue of human insulin. It is designed to provide a steady, basal level of insulin in the body for up to 24 hours. Unlike regular insulin, Insulin Glargine 100IU/ml Injection does not have a pronounced peak in its action. This makes it very useful for managing the background glucose levels that the body needs between meals and during the night. Insulin Glargine 100IU/ml Injection contains Insulin Glargine, which is modified to slow down its absorption into the bloodstream. This slow release helps in maintaining a stable blood sugar profile and reduces the risk of sudden drops in glucose levels.
At a glance
Insulin Glargine 100IU/ml Injection is a long acting insulin analogue.
It provides a steady level of insulin over 24 hours without a peak.
It is used to control blood glucose in Type 1 and Type 2 diabetes.
Uses of Insulin Glargine
- Management of Type 1 Diabetes Mellitus in adults and children.
- Management of Type 2 Diabetes Mellitus in adults.
- Use as a basal insulin to provide a constant background level of insulin.
- Combination therapy with rapid acting insulin for mealtime coverage.
- Control of nocturnal hyperglycemia in diabetic patients.
- Reduction of HbA1c levels in patients with poorly controlled diabetes.
Benefits of Insulin Glargine
Stable Glycemic Control
Insulin Glargine 100IU/ml Injection provides a peakless profile. This means it mimics the natural basal insulin secretion of the pancreas more closely than older insulins. It helps in keeping fasting blood glucose levels within the target range without causing sharp spikes or drops.
Reduced Hypoglycemia Risk
Because Insulin Glargine 100IU/ml Injection lacks a significant peak, the risk of nocturnal hypoglycemia is lower compared to NPH insulin. This allows patients to sleep more soundly and wake up with more predictable glucose levels. It simplifies the dosing regimen by requiring only one injection per day for basal needs.
Side effects of Insulin Glargine
The most common side effect of Insulin Glargine 100IU/ml Injection is hypoglycemia. This occurs when blood sugar levels drop too low, leading to symptoms like shaking, sweating, hunger, and dizziness. Some patients may experience lipodystrophy, which is the thickening or pitting of the skin at the injection site. This is usually caused by injecting into the same spot repeatedly. Allergic reactions can occur, ranging from mild redness and itching at the site to severe systemic reactions like anaphylaxis, though this is rare. Weight gain is also common as insulin helps the body utilize glucose more efficiently, which can lead to increased fat storage. Edema or swelling may occur during the initiation of therapy.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Hypoglycemia | Very common | Moderate | Consume fast acting glucose. |
| Lipodystrophy | Common | Mild | Rotate injection sites. |
| Local injection site reaction | Common | Mild | Apply a cold compress. |
How to manage side effects
Hypoglycemia
- Eat 15g of glucose
- Wait 15 minutes
- Recheck blood sugar
- Repeat if still low
Lipodystrophy
- Identify affected area
- Avoid injecting in lumps
- Use a site rotation map
- Consult doctor if skin worsens
Local injection site reaction
- Clean the area
- Apply cold pack
- Avoid rubbing the site
- Report persistent redness
How to use Insulin Glargine
- Inject Insulin Glargine 100IU/ml Injection subcutaneously into the abdomen, thigh, or upper arm.
- Always rotate the injection site to prevent skin changes like lipodystrophy.
- Administer the dose at the same time every day to maintain a steady state.
- Use a sterile needle for every injection and follow aseptic techniques.
- If using a pen, prime the pen by delivering 2 units of insulin before the actual dose.
Special population advice
Kidney impairment
- Reduce dose if eGFR is below 30 ml/min.
- Monitor blood glucose more frequently.
Liver impairment
- Use with caution in Child-Pugh class B or C.
- Adjust dose based on fasting glucose levels.
Children
- Dose based on body weight in kg.
- Supervise all injections to ensure correct dosing.
Elderly
- Start with a conservative dose.
- Increase monitoring for nocturnal hypoglycemia.
How Insulin Glargine works
Insulin Glargine 100IU/ml Injection works by binding to insulin receptors on the surface of cells. This triggers the movement of glucose from the blood into the muscles and liver. Insulin Glargine is soluble at an acidic pH but precipitates into micro crystals when it enters the neutral pH of the subcutaneous tissue. These crystals dissolve slowly, releasing the insulin into the blood at a constant rate over 24 hours.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Insulin Glargine 100IU/ml Injection, do not double the dose the next day. Contact your doctor immediately for guidance. Depending on the time of the miss, you may be advised to take it late or wait for the next scheduled dose. Monitor your blood glucose levels closely during this time.
In case of overdose
An overdose of Insulin Glargine 100IU/ml Injection leads to severe hypoglycemia. Symptoms include confusion, seizures, and loss of consciousness. Immediate treatment with fast acting glucose or an injection of glucagon is required. Hospitalization for intravenous dextrose may be necessary to stabilize blood sugar levels.
Used only for severe hypoglycemia when the patient is unconscious.
- Conscious Patient
- Administer 15 to 20 grams of fast acting carbohydrates like glucose tablets or fruit juice.
- Unconscious Patient
- Administer Glucagon 1 mg intramuscularly or subcutaneously.
- Monitoring
- Check blood glucose every 15 to 30 minutes until levels are stable.
- Hospitalization
- Provide intravenous 10 percent dextrose for severe or prolonged hypoglycemia.
Safety and precautions
When to avoid Insulin Glargine
- Hypoglycemia
Insulin should not be administered during an episode of low blood sugar.
- Hypersensitivity
Contraindicated in patients with a known allergy to insulin glargine.
- Renal Impairment
Requires dose reduction to avoid hypoglycemia.
- Hepatic Impairment
Increased risk of hypoglycemia due to reduced glucose production.
- Pregnancy
Close monitoring of glucose is needed as requirements change.
- Elderly Patients
Higher risk of hypoglycemia and decreased renal clearance.
Safety at a glance
Avoid excessive alcohol as it increases the risk of severe hypoglycemia.
Safe for use, but insulin doses often need adjustment during pregnancy.
Generally safe, but monitor the infant for signs of hypoglycemia.
Do not drive if you feel symptoms of hypoglycemia.
Reduce the dose in patients with severe renal impairment.
Use with care as liver failure increases the risk of hypoglycemia.
Do not use if you have a known allergy to insulin glargine.
Dosing must be carefully adjusted based on weight and age.
Start with lower doses due to increased sensitivity and renal decline.
Interactions
With other medicines
Propranolol
MajorChanges the medicine’s effect
What can happen: Masks tachycardia and tremors of hypoglycemia.
What to do: Monitor blood glucose more frequently and rely on sweating as a sign.
Prednisolone
ModerateChanges the medicine’s effect
What can happen: Increases blood glucose levels.
What to do: Increase insulin dose under medical supervision.
Enalapril
ModerateChanges the medicine’s effect
What can happen: Enhances the hypoglycemic effect of insulin.
What to do: Reduce insulin dose if hypoglycemia occurs frequently.
With food and drink
- AlcoholModerate
Increases the risk of hypoglycemia by inhibiting glucose release from the liver.
- Grapefruit juiceMinor
May cause minor fluctuations in blood glucose metabolism, monitor levels closely.
If you have another condition
- Chronic Kidney Disease
Reduced clearance of insulin can lead to prolonged action and hypoglycemia.
- Liver Cirrhosis
Impaired gluconeogenesis increases the risk of severe low blood sugar.
Effect on laboratory tests
- Blood Glucose Test
No effect
Standard glucometers accurately measure glucose levels during treatment.
- HbA1c
No effect
This test reflects average glucose and is not interfered with by the drug.
Quick tips
- Always carry a source of fast acting sugar, like glucose tablets or candy, to treat hypoglycemia.
- Rotate your injection sites daily to keep the skin healthy and ensure consistent absorption.
- Store unused pens or vials in the refrigerator, but keep the pen currently in use at room temperature.
- Monitor your blood glucose levels regularly as advised by your doctor to adjust the dose.
Counselling points
- Site RotationImportant
Rotate your injection sites every day to avoid lumps and ensure the insulin works correctly.
- HypoglycemiaImportant
Learn to recognize signs of low blood sugar like sweating and shaking. Always carry sugar.
- StorageGood to know
Keep unused pens in the fridge. The pen you are using can stay at room temperature for 28 days.
- TimingGood to know
Inject your dose at the same time every day to keep your blood sugar stable.
Monitoring during treatment
Before starting
- HbA1c
- Serum creatinine
- Liver function tests
During treatment
- every 3 months: Repeat HbA1c test
- daily: Fasting blood glucose monitoring
What is being watched
- Blood glucose
- HbA1c
- Body weight
Pharmacokinetics
- Absorption
- Slow absorption from subcutaneous tissue due to precipitation.
- Bioavailability
- High
- Protein binding
- Not applicable
- Volume of distribution
- Not specified
- Half-life
- Not applicable
- Metabolism
- Proteolysis by insulin degrading enzymes
- Excretion
- Renal and hepatic
- Onset / duration
- Onset 1 to 4 hours, duration up to 24 hours
Fact box
- Chemical class
- Protein
- Habit forming
- No
- Therapeutic class
- Antidiabetic
- Action class
- Basal insulin
- Storage
- Store unused pens and vials in the refrigerator at 2 to 8 degrees Celsius. Do not freeze. The pen in use can be stored at room temperature for up to 28 days.
- ATC code
- A10AB24
- Pregnancy category
- B
More information
Why clinicians prefer this basal insulin
Clinicians often choose Insulin Glargine 100IU/ml Injection as the first line basal insulin because of its predictable and peakless action. Traditional intermediate acting insulins like NPH have a peak that occurs several hours after injection. This peak often coincides with the middle of the night, leading to a high risk of nocturnal hypoglycemia. Insulin Glargine solves this problem by providing a flat, steady release of insulin. This stability allows the physician to titrate the dose more accurately to the patient's fasting glucose levels. It reduces the need for midnight snacks and improves the overall quality of sleep for the patient. The once daily dosing also significantly improves patient compliance compared to multiple daily injections of shorter acting insulins.
Comparison with other insulin analogues
Insulin Glargine 100IU/ml Injection is often compared with other long acting analogues like Insulin Detemir or Insulin Degludec. While all three provide basal coverage, Insulin Glargine is highly regarded for its 24 hour duration. Detemir may sometimes require twice daily dosing in some patients to maintain coverage. Degludec has an even longer half life and may be more flexible with timing, but Insulin Glargine 100IU/ml Injection has a longer track record of clinical use and extensive safety data. For most patients, Insulin Glargine 100IU/ml Injection provides the ideal balance of stability and predictability. The choice usually depends on the patient's specific risk of hypoglycemia and their ability to adhere to a strict daily schedule. In the Indian context, Insulin Glargine 100IU/ml Injection is widely available and well accepted by endocrinologists.
Lifestyle and dietary considerations
Managing diabetes with Insulin Glargine 100IU/ml Injection requires a coordinated approach to diet and exercise. Patients are encouraged to follow a balanced diet with a focus on complex carbohydrates and fiber. Since Insulin Glargine 100IU/ml Injection handles the basal needs, mealtime glucose spikes are managed by diet or rapid acting insulin. Exercise increases the sensitivity to insulin, which means the same dose of Insulin Glargine 100IU/ml Injection might cause a drop in blood sugar during or after physical activity. Patients should be advised to check their glucose levels before exercising and to carry a fast acting carbohydrate source. Alcohol consumption is a particular concern. Alcohol inhibits the liver from releasing glucose, which can lead to severe hypoglycemia when combined with Insulin Glargine. Patients should avoid drinking on an empty stomach.
What to expect during treatment
When starting Insulin Glargine 100IU/ml Injection, patients usually undergo a titration period. The doctor starts with a low dose and increases it gradually every few days based on fasting blood glucose readings. This prevents sudden hypoglycemia. Over the first few weeks, the patient may notice a gradual decrease in their morning glucose levels. It is common to experience some mild weight gain as the body begins to utilize glucose more effectively. Long term success is measured by the HbA1c level, which is checked every three months. Patients should expect to monitor their blood sugar daily. If they experience frequent hypoglycemia, the dose will be lowered. The goal is to achieve a target HbA1c, usually below 7 percent, while avoiding any episodes of severe low blood sugar.
References
- European Medicines Agency. Lantus, Summary of Product Characteristics.View sourceAccessed
- Electronic Medicines Compendium. Insulin Glargine, Summary of Product Characteristics.View sourceAccessed
- Rwanda FDA. Insulin Glargine Impact 100 units/ml, Summary of Product Characteristics.View sourceAccessed
- Sanofi. Insulin Glargine Impact SoloStar 100 UImL, Summary of Product Characteristics.View sourceAccessed
- Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed
Frequently asked questions about Insulin Glargine
Can I mix Insulin Glargine 100IU/ml Injection with other insulins in one syringe?
No, Insulin Glargine 100IU/ml Injection must not be mixed with any other insulin or solution. Mixing can change its pH and affect the slow release mechanism.
What should I do if I see a bubble in the pen?
Prime the pen by dialing 2 units and injecting them into the air until a drop appears at the needle tip.
Is Insulin Glargine 100IU/ml Injection the same as regular insulin?
No, it is a long acting analogue. Regular insulin works quickly and lasts a few hours, while Insulin Glargine 100IU/ml Injection lasts about 24 hours.
Can I stop taking Insulin Glargine 100IU/ml Injection once my sugar is normal?
No, you must not stop insulin without consulting your doctor, as this can lead to diabetic ketoacidosis.
Where is the best place to inject Insulin Glargine 100IU/ml Injection?
The abdomen is usually the fastest and most consistent site, followed by the thighs and upper arms.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →